ACTA1 and prostate cancer: The myofibroblastic marker alpha-smooth muscle actin α-SMA) is expressed by more than 50% of MSCs exposed to prostate cancer derived EVs vs. only 5% of cells under TGF-ß1 stimulation, which is known to induce α-SMA expression.